Biotech ETFs Brush Away Political Attacks on Drug Prices

This is another election year and one of the presidential variety, meaning investors and voters can expect to hear plenty about politicians’ efforts to lower drug costs. For now, biotech ETFs, such as the VanEck Vectors Biotech ETF ( BBH B- ) , are proving sturdy in the face of the drug cost headwinds.